<DOC>
	<DOC>NCT01108146</DOC>
	<brief_summary>To test overall efficacy of hydrocortisone on reexperience of traumatic memories (intrusions) and overall symptomatology in patients meeting criteria of complex chronic PTSD.</brief_summary>
	<brief_title>Hydrocortisone in the Treatment of Intrusions in Patients With Posttraumatic Stress Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders, Traumatic</mesh_term>
	<mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Written Informed Consent Female patients with PTSD according to DSMIV criteria (see Appendix 2). 1845 years Intrusions (according to IESR subscale Intrusions: Value: &gt; 7 Ability of subject to understand character and individual consequences of the clinical trial No participation in another clinical trial (up from 30 days before this trial) Lifetime diagnosis schizophrenia according to DSMIV Mental retardation Body mass index &lt; 16.5 Current drug and alcohol abuse and addiction Lifethreatening selfinjurious behavior in the last 4 months Suicide attempt with the strong intention to die in the last 4 months. Following diseases in anamnesis: stomach ulcera or intestinal ulcera, pancreatitis, corticoidinduced psychosis, severe osteoporosis, severe hypertension, heart failure, myasthenia gravis, asthma bronchiale, glaucoma, cataract, diabetes mellitus, herpes simples, herpes zoster (viremic phase), renal transplantation. Any pretreatment with hydrocortisone in the last 4 weeks prior to the first administration of Investigational Medicinal Product. Following current medication: cardiac glycosides, saluretics, antidiabetics, cumarinderivatives, rifampicine, phenytoine, barbiturates, primidone, NSAID, salicylate and indometacine, atropine, praziquantel, chloroquine, hydroxychloroquine, mefloquine, somatropine, protireline, cyclosporine, nondepolarising muscle relaxants. Pregnancy or lactation period Inadequate birth control (Adequate birth control: implants, injectables, combined oral contraceptives, intrauterine devices (IUDs), sexual abstinence or vasectomised partner) Shift working Intercontinental travel within 2 weeks prior to enrollment (to avoid jetlag) History of hypersensitivity to investigational medicinal product or to any drug with similar chemical structure or to any excipient present in the pharmaceutical form of the investigational medicinal product. No subject will be allowed to enrol in this trial more than once.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>